Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 3/20 | 0.44 |
| ▸ | TSHR | P16473 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | SMPD1 | P17405 | 4/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | DNM1 | Q05193 | 7/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL28112649 | 0.97 | FDPS (0.42) | FDPSTSHRLMNASMPD1THRB | |
| Hydrochloric Acid SCHEMBL28030433 | 0.97 | FDPS (0.42) | FDPSTSHRLMNASMPD1THRB | |
| SCHEMBL18462070 | 0.94 | FDPS (0.44) | FDPSTSHRSMPD1THRBDNM1 | |
| SCHEMBL22703594 | 0.94 | FDPS (0.44) | FDPSTSHRSMPD1THRBDNM1 | |
| SCHEMBL18534230 | 0.94 | FDPS (0.41) | FDPSTSHRLMNASMPD1THRB | |
| SCHEMBL7053194 | 0.94 | FDPS (0.41) | FDPSTSHRLMNASMPD1THRB | |
| SCHEMBL10397620 | 0.91 | SMPD1 (0.46) | FDPSTSHRSMPD1THRBDNM1 | |
| SCHEMBL13960421 | 0.91 | SMPD1 (0.46) | FDPSTSHRSMPD1THRBDNM1 | |
| SCHEMBL13120065 | 0.91 | SMPD1 (0.46) | FDPSTSHRSMPD1THRBDNM1 | |
| SCHEMBL3451668 | 0.91 | SMPD1 (0.46) | FDPSTSHRSMPD1THRBDNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 349 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116768697-A | Method for preparing dipropylmalonic acid by using chloropropane as alkylating agent and application of dipropylmalonic acid | 湖南大学 | 2023-09-19 | — | — | CN | claimed |
| CN-115399179-A | Application of polysaccharide-based cationic polymer in prevention and treatment of soil-borne diseases of agriculture and forestry | 中国科学院化学研究所 | 2022-11-29 | — | — | CN | claimed |
| EP-2601201-B1 | PROCESS FOR PREPARATION OF NOVEL 42-0-(HETEROALKOXYALKYL) RAPAMYCIN COMPOUNDS WITH ANTI-PROLIFERATIVE PROPERTIES\ | MERIL LIFE SCIENCES PVT LTD (IN) | 2014-09-24 | — | — | EP | claimed |
| US-20130184305-A1 | PROCESS FOR PREPARATION OF NOVEL 42-O-(HETEROALKOXYALKYL) RAPAMICIN COMPOUNDS WITH ANTI-PROLIFERATIVE PROPERTIES | MERIL LIFE SCIENCES PVT. LTD. (IN) | 2013-07-18 | — | — | US | claimed |
| EP-2601201-A1 | PROCESS FOR PREPARATION OF NOVEL 42-0-(HETEROALKOXYALKYL) RAPAMYCIN COMPOUNDS WITH ANTI-PROLIFERATIVE PROPERTIES\ | Meril Life Sciences Pvt. Ltd. (IN) | 2013-06-12 | — | — | EP | claimed |
| WO-2012017449-A1 | PROCESS FOR PREPARATION OF NOVEL 42-0-(HETEROALKOXYALKYL) RAPAMYCIN COMPOUNDS WITH ANTI-PROLIFERATIVE PROPERTIES\ | MERIL LIFE SCIENCES PVT. LTD (IN) | 2012-02-09 | — | — | WO | claimed |
| US-4410730-A | Process for the production of o-(N-monosubstituted amino)benzyl alcohols | SHIONOGI & CO., LTD. (JP) | 1983-10-18 | — | — | US | claimed |
| JP-6333785-A | — | — | None | — | — | JP | disclosed |
| CN-116444881-B | Polyethylene composition | 旭化成株式会社 | 2025-05-02 | — | — | CN | disclosed |
| WO-2025028374-A1 | COMPOSITION, TRANSFER FILM, METHOD FOR PRODUCING LAMINATE, LAMINATE, AND SEMICONDUCTOR PACKAGE | 富士フイルム株式会社 | 2025-02-06 | — | — | WO | disclosed |
| EP-1848750-B2 | COPOLYMERS AND FILMS THEREOF | INEOS SALES UK LTD (GB) | 2024-12-25 | — | — | EP | disclosed |
| EP-3660090-B1 | POLYETHYLENE COMPOSITION | ASAHI CHEMICAL IND (JP) | 2024-06-26 | — | — | EP | disclosed |
| WO-2024115426-A1 | POLYMERS CONTAINING SPIROTRUXENE DERIVATIVES AS THE REPEATING UNITS, AND ELECTROLUMINESCENT DEVICES CONTAINING SAID POLYMERS | MERCK PATENT GMBH (DE) | 2024-06-06 | — | — | WO | disclosed |
| EP-0218415-A1 | Process for intermediates to 1-carbapenems and 1-carbacephems | THE UNIVERSITY OF NOTRE DAME DU LAC (US) | 1987-04-15 | — | — | EP | disclosed |
| EP-0121088-B1 | NEW O-ACYL-ALKANEDIOL-PHOSPHOLIPIDS, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM | A. Nattermann & Cie. GmbH (DE) | 1986-10-01 | — | — | EP | disclosed |
| US-4610979-A | O-acyl-alkanediol-phospholipids and processes for the treatment of asthma | A. NATTERMANN & CIE GMBH (DE) | 1986-09-09 | — | — | US | disclosed |
| US-4565659-A | Substituted aminoalkanol phospholipids | A. NATTERMANN & CIE GMBH (DE) | 1986-01-21 | — | — | US | disclosed |
| EP-0121088-A1 | New o-acyl-alkanediol-phospholipids, processes for their preparation and pharmaceutical preparations containing them | A. Nattermann & Cie. GmbH (DE) | 1984-10-10 | — | — | EP | disclosed |
| US-4410730-A | Process for the production of o-(N-monosubstituted amino)benzyl alcohols | SHIONOGI & CO., LTD. (JP) | 1983-10-18 | — | — | US | disclosed |
| US-4190601-A | Production of tertiary amines by reductive alkylation | UNION CARBIDE CORPORATION (US) | 1980-02-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130184305-A1 | PROCESS FOR PREPARATION OF NOVEL 42-O-(HETEROALKOXYALKYL) RAPAMICIN COMPOUNDS WITH ANTI-PROLIFERATIVE PROPERTIES | MTOR, RICTOR, RPTOR | FDPS 796/4885TSHR 3839/4885LMNA 2386/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.